Status:

UNKNOWN

Elective vs Therapeutic Neck Dissection in Treatment of Early Node Negative Squamous Carcinoma of Oral Cavity

Lead Sponsor:

Tata Memorial Hospital

Conditions:

Oral Cancer

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Cervical nodal metastasis is the single most important prognostic factor in head and neck cancers. Appropriate management of the neck is therefore of paramount importance in the treatment of these can...

Detailed Description

Stratification criteria: 1. Size 2. Sex 3. Site 4. Sonography Randomization (I): All patients will be randomly allocated into one of two arms: wait and watch policy group or elective neck dissection...

Eligibility Criteria

Inclusion

  • Histologically proven T1 or T2 N0 M0 (clinical) squamous cell carcinoma of the buccal mucosa, lower alveolus, oral tongue and floor of mouth.
  • Surgery is the preferred treatment and the primary tumor can be excised with clear margins via the per-oral route.
  • No history of a prior malignancy in the head and neck region.
  • No prior malignancy outside the head and neck region in the preceding 5 years.
  • Patient will be reliable for follow-up
  • Age\> 18 years and \< 75 years.
  • No significant co-morbid conditions - ASA grade II and I.
  • Understands the protocol and is able to give informed consent.

Exclusion

  • Prior radiotherapy or surgery for malignancy in the head and neck region.
  • Non squamous cell carcinomas of the oral cavity.
  • Upper alveolus and palatal lesions where there is a possibility of retropharyngeal node involvement.
  • Per-oral excision of tumor will compromise margins in the opinion of the treating surgeon.
  • Significant co-existing pre-malignant conditions like erytho-leucoplakia and oral sub mucous fibrosis that in the opinion of the clinician would interfere in the planned treatment management of the patient.

Key Trial Info

Start Date :

January 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2019

Estimated Enrollment :

710 Patients enrolled

Trial Details

Trial ID

NCT00193765

Start Date

January 1 2004

End Date

June 1 2019

Last Update

June 16 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tata Memorial Hospital

Mumbai, Maharashtra, India, 400012